PRELUDIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Preludin, and when can generic versions of Preludin launch?
Preludin is a drug marketed by Boehringer Ingelheim and is included in two NDAs.
The generic ingredient in PRELUDIN is phenmetrazine hydrochloride. Additional details are available on the phenmetrazine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PRELUDIN?
- What are the global sales for PRELUDIN?
- What is Average Wholesale Price for PRELUDIN?
Summary for PRELUDIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 50 |
Patent Applications: | 4,047 |
DailyMed Link: | PRELUDIN at DailyMed |
US Patents and Regulatory Information for PRELUDIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Boehringer Ingelheim | PRELUDIN | phenmetrazine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 011752-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Boehringer Ingelheim | PRELUDIN | phenmetrazine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 011752-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Boehringer Ingelheim | PRELUDIN | phenmetrazine hydrochloride | TABLET;ORAL | 010460-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |